{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:13:59Z","timestamp":1791209639311,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ajo.2003.10.036","type":"journal-article","created":{"date-parts":[[2004,2,7]],"date-time":"2004-02-07T05:16:00Z","timestamp":1076130960000},"page":"337-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":329,"title":["Antiinflammatory therapy for dry eye"],"prefix":"10.1016","volume":"137","author":[{"given":"Stephen C.","family":"Pflugfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2003.10.036_BIB1","unstructured":"Matoba AY, Harris DJ, Mark DB, et al. Dry eye syndrome, preferred practice pattern. Am Acad Ophthalmol 1998, San Francisco, CA"},{"key":"10.1016\/j.ajo.2003.10.036_BIB2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0161-6420(98)96016-X","article-title":"The epidemiology of dry eye in Melbourne, Australia","volume":"105","author":"McCarty","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0420.1997.tb00774.x","article-title":"Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30-60 years","volume":"75","author":"Bjerrum","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2003.10.036_BIB4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly","volume":"124","author":"Schein","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"Moss","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2003.10.036_BIB6","first-page":"7","article-title":"Dry eye market set for robust growth","volume":"8","author":"Harmon","year":"2003","journal-title":"MarketScope"},{"key":"10.1016\/j.ajo.2003.10.036_BIB7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00003226-199801000-00007","article-title":"Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation","volume":"17","author":"Pflugfelder","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2003.10.036_BIB8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0161-6420(03)00245-8","article-title":"Assessing the severity of keratitis sicca with videokeratoscopic indices","volume":"110","author":"de Paiva","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archopht.1950.00910010231004","article-title":"Influence of age and sex of flow of tears","volume":"43","author":"Henderson","year":"1950","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-1-4615-0717-8_63","article-title":"Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions","volume":"506","author":"Sullivan","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB11","first-page":"321","article-title":"Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome","volume":"42","author":"Bacman","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0161-6420(01)00623-6","article-title":"Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface","volume":"108","author":"Battat","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004397-199403410-00008","article-title":"Systemic diseases associated with dry eye","volume":"34","author":"Fox","year":"1994","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajo.2003.10.036_BIB14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/path.1711430104","article-title":"Post-mortem prevalence of lymphocytic infiltration of lacrymal gland","volume":"143","author":"Nasu","year":"1984","journal-title":"J Pathol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB15","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0161-6420(90)32372-2","article-title":"Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sj\u00f6gren's syndrome","volume":"97","author":"Pepose","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4615-5359-5_2","article-title":"Influence of gender, sex steroid hormones and the hypothalamic-pituitary acis in the structure and function of the lacrimal gland","volume":"438","author":"Sullivan","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB17","doi-asserted-by":"crossref","unstructured":"McCollum CJ, Foulks GN, Bodner B, et al. Rapid assay of lactoferrin in keratoconjunctivitis sicca, Cornea 1994;13:505\u2013508","DOI":"10.1097\/00003226-199413060-00007"},{"key":"10.1016\/j.ajo.2003.10.036_BIB18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2003.10.036_BIB19","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB20","first-page":"2506","article-title":"Tear fluid gelatinase B activity correlates with IL-1\u03b1 concentration and fluorescein tear clearance","volume":"40","author":"Afonso","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4615-2417-5_83","article-title":"Tear osmolarity\u2014a new gold standard?","volume":"350","author":"Farris","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1440-1843.2002.00401.x","article-title":"p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate interleukin-8 and RANTES production in hyperosmolarity stimulated human bronchial epithelial cells","volume":"7","author":"Furuichi","year":"2002","journal-title":"Respirology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB23","unstructured":"Li D-Q, Chen Z, Song XJ, Farley W, Pflugfelder SC. Hyperosmolarity stimulates production of MMP-9, IL-1\u03b2 and TNF-\u03b1 by human corneal epithelial cells via a c-Jun NH2-terminal kinase pathway [Abstract]. Invest Ophthalmol Vis Sci 2002;43:E-Abstract 1981"},{"key":"10.1016\/j.ajo.2003.10.036_BIB24","unstructured":"Luo L, Li D-Q, Doshi A, Farley W, Pflugfelder SC. Experimental dry eye induced expression of inflammatory cytokines (IL-1\u03b1 and TNF-\u03b1), MMP-9 and activated MAPK by the corneal epithelium [Abstract]. Invest Ophthalmol Vis Sci 2003;44:E-Abstract 1026"},{"key":"10.1016\/j.ajo.2003.10.036_BIB25","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.274.5290.1194","article-title":"Ultraviolet light and osmotic stress","volume":"274","author":"Rosette","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ajo.2003.10.036_BIB26","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Boudouin","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Ann Rev Cell Dev Biol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB28","first-page":"853","article-title":"TGF-beta increases retinal endothelial cell permeability by increasing MMP-9","volume":"42","author":"Behzadian","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB29","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia","volume":"21","author":"Asahi","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1076\/ceyr.16.2.158.5085","article-title":"Changes in rat corneal matrix metalloproteinases and serine proteinases under vitamin A deficiency","volume":"16","author":"Twining","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2003.10.036_BIB31","unstructured":"Pflugfelder SC, Farley W, Li D-Q, Song X, Fini E. Matrix metalloproteinase-9 (MMP-9) knockout alters the ocular surface response to experimental dryness [Abstract]. Invest Ophthalmol Vis Sci 2002;43:E-Abstract 3124"},{"key":"10.1016\/j.ajo.2003.10.036_BIB32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00003226-199811000-00014","article-title":"The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca","volume":"17","author":"Gao","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2003.10.036_BIB33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1167\/iovs.02-0581","article-title":"Apoptosis of ocular surface cells in experimentally induced dry eye","volume":"44","author":"Yeh","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB34","unstructured":"Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival apoptosis in experimental murine keratoconjunctivitis sicca [Abstract]. Invest Ophthalmol Vis Sci 2002;43:E-Abstract 2514"},{"key":"10.1016\/j.ajo.2003.10.036_BIB35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/jme.0.0280069","article-title":"Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids","volume":"28","author":"Almawi","year":"2002","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/pupt.2001.0283","article-title":"Glucocorticoid-regulated transcription factors","volume":"14","author":"Adcock","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ajo.2003.10.036_BIB37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13684730412331302081","article-title":"Molecular aspects of glucocorticoid action in rheumatoid arthritis","volume":"7","author":"Neeck","year":"2002","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.ajo.2003.10.036_BIB38","first-page":"2544","article-title":"Doxycycline inhibition of interleukin-1 in the corneal epithelium","volume":"41","author":"Solomon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/ajrccm.162.3.9911099","article-title":"Inhalant corticosteroids inhibit hyperosmolarity-induced, and cooling and rewarming-induced interleukin-8 and RANTES production by human bronchial epithelial cells","volume":"162","author":"Hashimoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajo.2003.10.036_BIB40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9394(01)00913-8","article-title":"Treatment of recalcitrant recurrent corneal epithelial erosions with inhibitors of matrix metalloproteinases-9, doxycycline and corticosteroids","volume":"132","author":"Dursun","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1006\/bbrc.2000.3079","article-title":"Glucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 gene","volume":"273","author":"Liden","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajo.2003.10.036_BIB42","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0091-6749(99)70183-1","article-title":"Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells","volume":"103","author":"Aksoy","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.cdd.4400854","article-title":"Regulation of cell death and survival in intestinal intraepithelial lymphocytes","volume":"8","author":"Brunner","year":"2001","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajo.2003.10.036_BIB44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/01616412.1999.11740966","article-title":"Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils","volume":"21","author":"Yoshida","year":"1999","journal-title":"Neurol Res"},{"key":"10.1016\/j.ajo.2003.10.036_BIB45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical non-preserved methylprednisolone therapy of keratoconjunctivitis sicca in Sjogren's syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB46","first-page":"751","article-title":"Nonpreserved topical steroids and punctual occlusion for severe keratoconjunctivitis sicca","volume":"75","author":"Sainz de la Maza Serra","year":"2000","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB47","doi-asserted-by":"crossref","unstructured":"Maskin SL, Anderson B, Chodosh J, et al. Loteprednol etabonate 0.5% (Lotemax) versus vehicle in the management of patients with KCS and at least moderate inflammation [Abstract]. Invest Ophthalmol Vis Sci 2003;44:E-Abstract 686","DOI":"10.1167\/iovs.02-0828"},{"key":"10.1016\/j.ajo.2003.10.036_BIB48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0300-9084(02)01375-5","article-title":"The permeability transition pore complex","volume":"84","author":"Halestrap","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.ajo.2003.10.036_BIB50","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1989.01070020276038","article-title":"Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca","volume":"107","author":"Kaswan","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB51","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome","volume":"72","author":"Gunduz","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003226-199307000-00007","article-title":"Pilot trial of cyclosporin 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca","volume":"12","author":"Laibovitz","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2003.10.036_BIB53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease\u2014a dose-ranging, randomized trial","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB55","unstructured":"Brignole F, Pisella PJ, Saint Jean M, et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001;42:90\u201395"},{"key":"10.1016\/j.ajo.2003.10.036_BIB56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2003.10.036_BIB57","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome","volume":"118","author":"Kunert Arch Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/exer.2001.1054","article-title":"Regulation of MMP-9 in human corneal epithelial cells","volume":"73","author":"Li","year":"2001","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2003.10.036_BIB59","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines","volume":"93","author":"Amin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajo.2003.10.036_BIB60","doi-asserted-by":"crossref","first-page":"31504","DOI":"10.1074\/jbc.272.50.31504","article-title":"Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline","volume":"272","author":"Hanemaaijer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2003.10.036_BIB61","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/1529-0131(199904)42:4<719::AID-ANR15>3.0.CO;2-T","article-title":"Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes","volume":"42","author":"Shlopov","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2003.10.036_BIB62","first-page":"1703","article-title":"Stromelysin (MMP-3) activates pro-MMP-9 secreted by corneal epithelial cells","volume":"41","author":"Sobrin","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.036_BIB63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1902\/jop.2002.73.7.762","article-title":"Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis","volume":"73","author":"Novak","year":"2002","journal-title":"J Periodontol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1034\/j.1600-051x.2002.290204.x","article-title":"Non-surgical periodontal therapy with adjunctive topical doxycycline","volume":"29","author":"Eickholz","year":"2002","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea","volume":"116","author":"Frucht-Pery","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003226-199503000-00005","article-title":"Meibomian gland dysfunction and tear film abnormalities in rosacea","volume":"14","author":"Zengin","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2003.10.036_BIB67","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0161-6420(97)30015-3","article-title":"Ocular rosacea","volume":"104","author":"Akpek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB68","doi-asserted-by":"crossref","unstructured":"Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ, Jones HS. Oral tetracycline in the treatment of recurrent corneal erosions. Eye 1994; 8:384\u2013388","DOI":"10.1038\/eye.1994.91"},{"key":"10.1016\/j.ajo.2003.10.036_BIB69","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0161-6420(93)31475-2","article-title":"Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline","volume":"100","author":"Culbertson","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.036_BIB70","first-page":"515","article-title":"Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients","volume":"19","author":"Liou","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.20020439","article-title":"Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis","volume":"196","author":"Ji","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajo.2003.10.036_BIB72","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1055\/s-0037-1616098","article-title":"Fibrinolysis\/proteolysis balance in stable angina pectoris in relation to angiographic findings","volume":"86","author":"Paramo","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajo.2003.10.036_BIB73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2003.10.036_BIB74","first-page":"339","article-title":"Beneficial effect of the local application of plasma fibronectin and autologous serum in patients with keratoconjunctivitis sicca of Sjogren's syndrome","volume":"26","author":"Kono","year":"1986","journal-title":"Ryumachi"},{"key":"10.1016\/j.ajo.2003.10.036_BIB75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous seum application in Sjogren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.036_BIB76","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(00)00822-9","article-title":"The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects","volume":"131","author":"Yen","year":"2001","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939403013230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939403013230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:46:39Z","timestamp":1757594799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939403013230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0002939403013230"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2003.10.036","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiinflammatory therapy for dry eye","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2003.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}